ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Luke Li Senior VP, Head of Business Development and a Board Member of Cold Genesys, a phase III immune-oncology company in California. Was Executive Director, Head of Global Biotherapeutic Technologies, Bio-Innovation for Pfizer from April 2010 to May 2015

Luke Li & BOD

According to BioCentry publication entitled Infectious Enthusiasm (page 5) list the Cold Genesys Phase III bladder cancer trial as one of the most advanced in the list Oncolyptic Pipeline.

Primary completion (Final data collection date for primary outcome measure) of the Phase III trial is June 2017.
Trial

ANI originally owned 19.9% of Cold Genesys. I don't know what stake they own now but Art Przybyl is still on their Board of Directors.

It will be interesting to see if Pfizer will make a play for Cold Genesys.